Results 291 to 300 of about 1,006,225 (339)

ASO Author Reflections: Organoid Model to Aid the Decision of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. [PDF]

Ann Surg Oncol
Liu D, Yang K, Cai J.
europepmc   +1 more source

Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy applications in upper and lower gastrointestinal cancer, a review. [PDF]

Oncol Rev
Drittone D, Schipilliti FM, Arrivi G, Mazzuca F.   +3 more
europepmc   +1 more source

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis. [PDF]

Br J Surg
Hamm JJM, van den Berg R, Andrinopoulou ER, Zwanenburg ES, Musters GD, Tanis PJ, Arjona-Sanchez A, COLOPEC and HIPECT4 Collaborator Groups .   +7 more
europepmc   +1 more source

Single center experience with Hypotension Prediction Index (HPI) during cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). [PDF]

J Anesth Analg Crit Care
L'Acqua C, Frassanito L, Kusamura S, Valenza F.   +3 more
europepmc   +1 more source

Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA). [PDF]

Cancer Diagn Progn
Asano Y, Yonemura Y, Hozumi C, Mizuta K, Kang BM, Kim JS, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Morinaga S, Tsuchiya H, Demura S, Hoffman RM.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

INTRAPERITONEAL CHEMOTHERAPY

Obstetrics and Gynecology Clinics of North America, 1994
Despite high initial tumor response rates to systemically administered platinum-based chemotherapy, fewer than one quarter of advanced-stage ovarian cancer patients currently experience prolonged disease-free survival. Because persistent and relapsed disease tends to remain confined to the peritoneal cavity, the strategy of enhancing drug delivery to ...
Michael F. Flessner, Robert L. Dedrick
  +6 more sources

Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.

JAMA Oncology, 2021
Importance The peritoneal surface is a common site of disease in ovarian and colorectal cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts, including surgical removal of tumor deposits and intravenous chemotherapy ...
R. V. van Stein, A. Aalbers, G. Sonke, W. V. van Driel   +3 more
semanticscholar   +1 more source

Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial

Journal of Surgical Oncology, 2021
The PERISCOPE I (Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyPErthermic intraperitoneal chemotherapy) study was conducted to investigate the safety and feasibility of hyperthermic intraperitoneal ...
W. Koemans, R. T. van der Kaaij, E. Wassenaar, D. Boerma, H. Boot, K. Sikorska, M. Los, C. Grootscholten, K. Hartemink, A. Veenhof, L. Kodach, P. Snaebjornsson, J. V. van Sandick   +12 more
semanticscholar   +1 more source